• Aperio Technologies (Vista, California) reported that it has received FDA clearance to market the ER and PR image analysis applications available through its ScanScope slide-scanning system. The immunohistochemistry image analysis applications are intended to be used as an aid to pathologists in detecting and quantifying ER (estrogen receptor) and PR (progesterone receptor) protein expressions from digital slide images created by the company's slide-scanning systems. Aperio's FDA clearance encompasses the company's digital pathology system, including ScanScope scanners for creating digital slide images from microscope slides, the Spectrum digital pathology information management system for managing, viewing, and analyzing digital slides, and the specific image analysis applications which perform the automated scoring of ER and PR breast cancer digital slides. Aperio specializes in digital pathology.

• Cambridge Research & Instrumentation (Woburn, Massachusetts) reported the release of the Maestro EX in vivo imaging system. The system uses Cri's FLEX technology for in vivo fluorescence imaging. The company said Maestro software tools complement the improved optical capabilities of the Maestro EX by ensuring accurate and automated characterization of fluorescent signals in spectrally complex samples. Dynamic contrast enhancement (DyCE) is available as an accessory. DyCE is an all-optical anatomic imaging solution for mice that also helps eliminate signals from non-specific binding in much less time than conventional means — by as much as 90% less time. Cambridge Research & Instrumentation specializes in optical imaging.

• Healthcare Providers Direct (Lawrenceville, New Jersey has introduced Colon Health Check, a self-administered diagnostic test that allows for accurate screening for colon cancer at home. Colon Health Check detects the presence of blood in stool – a major symptom of colorectal cancer and other gastrointestinal (GI) disorders – and provides a negative or positive result to the test user within five minutes. Colon Health Check is an FDA-approved immunochemical-based fecal-occult blood test.

• Home Diagnostics (Fort Lauderdale, Florida) said that it received FDA clearance for its blood glucose meter, TRUE2go, and for TRUEresult, the company's latest advanced-performance, no-coding meter for at-home testing. The TRUE systems feature no-coding technology that helps simplify blood glucose testing by eliminating the need for users to code the meter with each new box of test strips. Both TRUE2go and TRUEresult deliver precise results in as fast as four seconds using only 0.5 microliters of blood. Home Diagnostics makes diabetes management solutions.

• Lumedx (Oakland, California) and Epiphany Cardiography (Amherst, Virginia) introduce CardioECG 3.2, multi-modality, multi-vendor, pure-Web software for cardiac rhythm data management. The software is designed to deliver clinical data from over 60 different devices and over 30 vendors across 10 different modalities such as cardiograph, Holter, stress, patient monitoring, PFT, and defibrillator. The companies claim that the CardioECG 3.2 eliminates expenses associated with regular, costly hardware and software upgrades and sunsetting of older systems; offers pure Web access — edit, review, confirm and print diagnostic-quality ECGs from any network-connected PC in the hospital, office, home or even via iPhone; and enables robust multi-site communications and support without the high costs related to proprietary systems. Lumedx makes cardiovascular imaging and information systems.

• Nomir Medical Technologies (Waltham, Massachusetts) said it will present an abstract detailing positive in vitro and in vivo human data from its study of onychomycosis (toenail fungus) using Noveon, a dual-wavelength optical energy device. Noveon is designed to effect near-infrared photo-inactivation of fungi and bacteria at energies and temperatures that are safe to normal and healthy tissue. The data will be presented in a digital session at the New Cardiovascular Horizons "Wound Management of the Diabetic Foot and Wound Healing" conference in New Orleans, Sept. 10-13. Nomir Medical Technologies makes optical energy technologies for anti-infective medical applications.

• ProSolv CardioVascular (Indianapolis) reported the release of ProSolv CardioVascular 4.0. This new software release features ProSolv as a web-based application for full viewing and reporting capabilities using web communication protocols, secured via SSL, in addition to a web URL single-click application download and installation for easier deployment of the application. Other enhancements include new advanced clinical tools to further aid the diagnostic process, and the full integration to Fujifilm Medical Systems' Synapse picture archiving and ommunications system. ProSolv CardioVascular, a Fujifilm company, makes information management solutions for the clinical analysis and management of digital medical images for cardiology.

• Roche Applied Science (Penzberg, Germany) reported the introduction of the MagNA Pure LC 2.0 system. The company says it now meets all requirements for a modern nucleic acid purification system. The system provides isolation of pure nucleic acids from various sample materials is crucial for sensitive molecular analysis by PCR, RT-PCR, sequencing and arrays. This fully automated system is based on the magnetic bead technology and is designed to automate nucleic acid purification and PCR setup in the medium- to high-throughput range, flexibly processing one to 32 samples at a time. The duration to purify a full batch of 32 samples is 52 to 180 minutes, depending on the application. Roche is a research-focused healthcare group in the fields of pharmaceuticals and diagnostics.

No Comments